Cardiovascular Risk Profile | Serum
Cardiovascular disease (CVD) is associated with more deaths than all cancers—and more deaths in women than breast cancer. This Cardiovascular Risk Profile evaluates a thorough battery of traditional and advanced biomarkers to aid in early detection and modification of risk factors. Doctor’s Data measures the activity of lipoprotein-associated phospholipase-A2 (PLAC®), as well as the true LDL culprits; oxidized LDL, small dense LDL and Lp(a), which are higher in CVD patients and correlated with the severity of CVD. A total of thirteen primary and secondary risk factors are evaluated to provide actionable information at a tremendous value.
Useful for:
- Cardiovascular Disease
- Lipid/Lipoprotein Profile
- Heart Attack
- Peripheral Arterial Disease
- Stroke
- Cardioprotective Nutrient Status
- Inflammation
Analytes Tested:
- Apolipoprotein, A1; serum
- Apolipoprotein, B, serum
- C-Reactive Protein; serum
- HDL Cholesterol; serum
- Homocysteine; serum
- LDL Cholesterol; calculated
- Lipoprotein (a), serum
- Non-HDL Cholesterol; calculated
- Oxidized LDL; serum
- PLAC (LP-PLA2 Activity); serum
- Small dense LDL Cholesterol; calculated
- Total Cholesterol; serum
- Triglycerides; serum
- VLDL Cholesterol; calculated
Turnaround Time
5 to 7 days
Note: Turnaround times on results are an estimate and are not guaranteed. The lab may need additional time due to holidays, confirmation/repeat testing, etc. You can contact us to discuss when your results should be ready.